Mr. Singh is a retired Indian Navy Officer with an extensive background in government contracting and maritime consulting. He holds a BS in Political Science from Delhi University, India, and a Master's in Business Administration from Symbiosis Institute of Management in Pune, India. Mr. Singh founded Nelson Scientific Labs LLC in 2018 with a primary goal of translating tests developed in the laboratory to in vitro diagnostics for the health and medicine market. He currently serves as Nelson's President and Chief Executive Officer.

Dr. Cheema is a professor of Oncology and Biochemistry and co-director of the Waters Center of Innovation in Metabolomics at the Georgetown University Medical Center. Her research focuses on discovery and development of small-molecule biomarkers of exposure to ionizing radiation and adverse health outcomes of radiation therapy. Dr. Cheema's laboratory has also advanced molecular phenotyping with the development of reliable workflows and informatics tools.

Dr. Tyburski is a public health researcher interested in developing biomarkers of exposure and late health effects. Working at the intersection of machine learning and epidemiology, he is developing methods to assess individual susceptibility to accidental and therapeutic radiation exposures. Dr. Tyburski holds a BS in Organismal Biology and a PhD in Physiology and Cell Biology from the University of Kansas as well as a Master of Public Health from the Johns Hopkins Bloomberg School of Public Health. Dr. Tyburski currently serves as Scientific Advisor at Nelson Scientific Labs.

Dr. Kanholm is a bioinformatics scientist specializing in big-data analysis and pipeline automation. His current research interests include analysis of LCMS and other data sources to uncover biomarkers of radiation related late health effects. He holds a BS in Psychobiology from the University of California Los Angeles and a PhD in Genomics and Bioinformatics from the George Washington University as well as an MS in Biochemistry from the University of Southern California.

Dr. Jessica Paredes is an analytical chemist and a bioinformatic scientist. Her research focuses on the analysis of multi-omics data from human patients and animal models to reveal biomarkers for radiation-based cardiac disease. She holds a BA in chemistry from New College of Florida and a PhD in chemistry from Vanderbilt University, where she specialized in using proteomics to reveal important mechanisms related to aging and age-related nuclear cataracts.

Pradeep Thapaliya is a Lead Application Developer and System Architect at Nelson Scientific Labs. With a Master's degree in Computer Science from the Illinois Institute of Technology, he has extensive experience in designing, building, testing, and managing infrastructure for complex software systems. His expertise includes application development, system architecture, system design, test suite design, testing, infrastructure as code, and implementing CI/CD pipelines.

Ms. Soni is HR & Finance Admin. She has been finance and admin professional with over 25 years of experience in the field. She holds a Bachelors in Business from Delhi University India . Ms. Soni has worked in various industries including healthcare, finance, and government contracting. She currently serves as the Admin & HR Manager at Nelson Scientific Labs.

Dr. Dritschilo currently serves as Chairman and Chief Exectutive Officer of Shuttle Pharmaceuticals, a company he co-founded in 2012. A radiation oncologist by training, Dr. Dritschilo holds a BS degree in Chemical Engineering from the University of Pennsylvania, a medical degree from the College of Medicine of New Jersey, and residency training from Harvard University's Joint Center of Radiation Therapy.

Dr. Unger currently serves as the Interim Chief of Radiation Oncology and Director of the Gastrointestinal Cancer Service, as well as director of the residency training for the Department of Radiation Oncology at MedStar Georgetown University Hospital. He also fulfills the role of Acting Academic Chair of the Department of Radiation Medicine at Georgetown University School of Medicine, where he is a Professor. Dr. Unger's leadership extends to chairing the hospital's cancer committee.

Dr. Jill Smith is clinician scientist and Professor of Medicine at Georgetown University and the Lombardi Comprehensive Cancer Center. Dr. Smith also practices GI/Hepatology at the Washington DC Veterans Affairs Medical Center. As a clinical scientist, Dr. Smith's passion has been bench-to-bedside translational research. She has a basic science lab and is also conducting clinical trials in liver and pancreatic diseases.

Dr. Ressom is a Professor of in the Department of Oncology at Georgetown University and serves as the Scientific Director for OmicsCraft LLC in Washington, DC. He has many years of experience in developing algorithms using machine learning, fuzzy logic, and network-based methods for omics data analysis. His research interest focuses on identification of disease biomarkers using multi-omics approaches.

I have been a consultant for regulatory strategy within Regulatory Pathfinders (since 2017), for therapeutics and diagnostics companies in precision medicine, digital, imaging, and AI products. My consulting work includes Senior Vice President for Regulatory and Quality at Ariana Data Intelligence, a US subsidiary of Ariana Pharma in France. At Ariana (since 2021), I’ve led the alignment of AI product development and regulatory strategies for Ariana Pharma customers. I am currently working with the team at Nelson Scientific Labs. LLC for FDA approval of the CardioWatch device. I work with Nelson to extend the scope of work towards the approval of the Kidney-Watch and Lung-Watch devices as an exciting next step in my consulting experience.